Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura.
about
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraCurrent concepts in thrombotic thrombocytopenic purpuraDeficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura.Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow.Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.Chronic relapsing thrombotic thrombocytopenic purpura successfully treated with rituximab: case report.Thrombotic thrombocytopenic purpura: survival by "giving a dam"ADAMTS13 and microvascular thrombosisRemission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura.The kidney in thrombotic thrombocytopenic purpura.A case series of atypical presentations of thrombotic thrombocytopenic purpura.Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis.Atypical thrombotic thrombocytopenic purpura in a middle-aged woman who presented with a recurrent stroke.Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency.Pearls and oy-sters: acute ischemic stroke caused by atypical thrombotic thrombocytopenic purpura.Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.Why Do We Need ADAMTS13?Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions.Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report.Thrombotic thrombocytopenic purpuraRituximab in recalcitrant thrombotic thrombocytopenic purpura secondary to systemic lupus erythematosus
P2860
Q24651320-02F50C68-1CD0-401E-9B96-232EC22A6853Q24656680-7D02F335-C45C-44E5-994D-61DF9EB1EB41Q33349696-13565952-A163-403E-A666-BD544007E2CCQ33359900-E8733BFA-22BD-4667-9AF3-D57F3EE6DBF2Q33361703-D0E5F3F9-3A3A-4275-88C9-4ADA0DBF8B88Q33368176-34B7B313-3B93-484C-8FAB-4C189FC2FCEDQ33368490-934554B6-A5F2-424E-8333-F5E29FE6E393Q33373067-4FD59568-51CD-486D-83BE-DDC089F88CC6Q33373608-70F0DAF6-AECE-449B-AAAB-464C607BDD73Q33373912-B1507635-38E9-480B-BFA2-212631D59ED7Q33374294-3EE616AB-E9B2-494D-B312-91704EF623EAQ33378755-F21E87A6-C021-4678-B361-0463501740E5Q33400508-7E0081AB-E06E-43C9-BD46-C3F8B0E9150CQ33401010-EC9C4315-BB0D-489D-81AC-F37D109ACF37Q33401469-AB377677-6FCB-4C42-94E2-FE5D55720FECQ33402998-742D9F4A-4DE7-4D0B-B987-57E76F13BEA5Q33408007-B8D9BF3A-76DB-4068-9701-5905AD9312F6Q33429930-211767EA-807B-4A6D-87C3-9F9E5845DDF5Q35062975-A0F230C3-D62E-4284-A2EE-796EFEAD6356Q35848128-8E5B71F3-BCB6-4510-BFF6-A59052A46E28Q53476115-FB454A1F-CDB2-4435-A326-A33AD85089A8Q57591162-82D36E2E-43C0-479D-9FEC-47BF87122C44Q58482137-8026C5AD-9AEE-4DB5-8FC6-DB0F4B538CC0
P2860
Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Rituximab induces remission of ...... otic thrombocytopenic purpura.
@ast
Rituximab induces remission of ...... otic thrombocytopenic purpura.
@en
type
label
Rituximab induces remission of ...... otic thrombocytopenic purpura.
@ast
Rituximab induces remission of ...... otic thrombocytopenic purpura.
@en
prefLabel
Rituximab induces remission of ...... otic thrombocytopenic purpura.
@ast
Rituximab induces remission of ...... otic thrombocytopenic purpura.
@en
P2860
P1476
Rituximab induces remission of ...... otic thrombocytopenic purpura.
@en
P2093
Han-Mou Tsai
Keith Shulman
P2860
P304
P356
10.1034/J.1600-0609.2003.00026.X
P577
2003-03-01T00:00:00Z